Antimicrobial activity of the ASD-2F

Q4 Medicine

Infektsionnye Bolezni Pub Date : 2021-01-01 DOI:10.20953/1729-9225-2021-3-104-108

S. Engashev, V. Kukes, A. Poddubikov, N. G. Sidorov, O. K. Parfenova, A. Leonova, O. Dorogova

{"title":"Antimicrobial activity of the ASD-2F","authors":"S. Engashev, V. Kukes, A. Poddubikov, N. G. Sidorov, O. K. Parfenova, A. Leonova, O. Dorogova","doi":"10.20953/1729-9225-2021-3-104-108","DOIUrl":null,"url":null,"abstract":"The second fraction of antiseptic Dorogov's stimulator (ASD-2F) is a derivative of raw biological materials, namely a mixture of products of thermal protein degradation. ‘ASD-2B drops’ is dietary supplement containing ASD-2F. Each component of ‘ASD-2B drops’ plays a role in some processes of a living organism. ASD-2F affects the functional activity of many organs and systems of the body and increases the resistance to negative factors, such as microorganisms causing various infectious diseases. The development of multidrug resistance by many microorganisms necessitates the search for new antimicrobial agents. In this study, we examined antimicrobial properties of ‘ASD-2B drops.’ We found that this substance affected the growth of the majority of microorganisms used in our experiments. The therapeutic dose recommended by the manufacturer demonstrated the most pronounced antimicrobial effect, which indicates the effectiveness of ‘ASD 2B drops’ in this dose. Our findings suggest that ASD-2F might have a high clinical significance. Key words: ‘ASD-2B drops,’ second fraction of antiseptic Dorogov's stimulator, antimicrobial activity","PeriodicalId":37794,"journal":{"name":"Infektsionnye Bolezni","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infektsionnye Bolezni","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20953/1729-9225-2021-3-104-108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

The second fraction of antiseptic Dorogov's stimulator (ASD-2F) is a derivative of raw biological materials, namely a mixture of products of thermal protein degradation. ‘ASD-2B drops’ is dietary supplement containing ASD-2F. Each component of ‘ASD-2B drops’ plays a role in some processes of a living organism. ASD-2F affects the functional activity of many organs and systems of the body and increases the resistance to negative factors, such as microorganisms causing various infectious diseases. The development of multidrug resistance by many microorganisms necessitates the search for new antimicrobial agents. In this study, we examined antimicrobial properties of ‘ASD-2B drops.’ We found that this substance affected the growth of the majority of microorganisms used in our experiments. The therapeutic dose recommended by the manufacturer demonstrated the most pronounced antimicrobial effect, which indicates the effectiveness of ‘ASD 2B drops’ in this dose. Our findings suggest that ASD-2F might have a high clinical significance. Key words: ‘ASD-2B drops,’ second fraction of antiseptic Dorogov's stimulator, antimicrobial activity

查看原文本刊更多论文

ASD-2F的抗菌活性

抗菌多罗戈夫刺激剂(ASD-2F)的第二组分是原始生物材料的衍生物，即热蛋白降解产物的混合物。“ASD-2B滴剂”是一种含有ASD-2F的膳食补充剂。“ASD-2B滴剂”的每个组成部分在生物体的某些过程中发挥作用。ASD-2F影响身体许多器官和系统的功能活动，增加对负面因素的抵抗力，如引起各种传染病的微生物。许多微生物对多种药物产生耐药性，这就要求寻找新的抗微生物药物。在这项研究中，我们检测了ASD-2B滴剂的抗菌性能。“我们发现这种物质影响了我们实验中使用的大多数微生物的生长。制造商推荐的治疗剂量显示出最明显的抗菌效果，这表明“ASD 2B滴剂”在该剂量下的有效性。我们的研究结果表明，ASD-2F可能具有很高的临床意义。关键词:ASD-2B滴剂;多罗戈夫刺激剂;抗菌活性

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Infektsionnye Bolezni Medicine-Infectious Diseases

CiteScore

1.30

自引率

0.00%

发文量

期刊介绍： The journal publishes original research works, reviews of literature, lectures, methodological recommendations, clinical observations. Main topics: problems of etiology, pathogenesis, clinical manifestations of infectious diseases, new techniques and methods of their diagnosis, prevention and treatment; special attention is paid to the problems of antibacterial and antiviral therapy, the use of immunoglobulins and interferons, and also to intensive therapy of critical states. The journal is in the List of leading scientific journals and periodicals of the Supreme Attestation Committee, where the principal results of doctoral dissertations should be published.